HomeCompareGILD vs WM

GILD vs WM: Dividend Comparison 2026

GILD yields 2.34% · WM yields 1.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WM wins by $49.3K in total portfolio value· pulled ahead in Year 3
10 years
GILD
GILD
● Live price
2.34%
Share price
$136.34
Annual div
$3.19
5Y div CAGR
17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$1,614.90
Full GILD calculator →
WM
WM
● Live price
1.49%
Share price
$229.96
Annual div
$3.42
5Y div CAGR
51.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.4K
Annual income
$25,153.90
Full WM calculator →

Portfolio growth — GILD vs WM

📍 WM pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGILDWM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GILD + WM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GILD pays
WM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GILD
Annual income on $10K today (after 15% tax)
$198.88/yr
After 10yr DRIP, annual income (after tax)
$1,372.67/yr
WM
Annual income on $10K today (after 15% tax)
$126.41/yr
After 10yr DRIP, annual income (after tax)
$21,380.82/yr
At 15% tax rate, WM beats the other by $20,008.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GILD + WM for your $10,000?

GILD: 50%WM: 50%
100% WM50/50100% GILD
Portfolio after 10yr
$53.8K
Annual income
$13,384.40/yr
Blended yield
24.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GILD right now

GILD
Analyst Ratings
37
Buy
20
Hold
1
Sell
Consensus: Buy
Price Target
$158.71
+16.4% upside vs current
Range: $105.00 — $180.00
Altman Z
4.1
Piotroski
8/9
WM
Analyst Ratings
19
Buy
16
Hold
Consensus: Buy
Price Target
$253.75
+10.3% upside vs current
Range: $238.00 — $264.00
Altman Z
2.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GILD buys
0
WM buys
0
No recent congressional trades found for GILD or WM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGILDWM
Forward yield2.34%1.49%
Annual dividend / share$3.19$3.42
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17.3%51.2%
Portfolio after 10y$29.1K$78.4K
Annual income after 10y$1,614.90$25,153.90
Total dividends collected$7.6K$53.6K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$158.71$253.75

Year-by-year: GILD vs WM ($10,000, DRIP)

YearGILD PortfolioGILD Income/yrWM PortfolioWM Income/yrGap
1$10,974$274.45$10,925$224.87+$49.00GILD
2$12,073$330.19$12,037$347.14+$36.00GILD
3← crossover$13,316$398.20$13,420$540.47$104.00WM
4$14,730$481.49$15,211$851.48$481.00WM
5$16,345$583.87$17,639$1,363.78$1.3KWM
6$18,199$710.26$21,109$2,234.83$2.9KWM
7$20,340$866.96$26,366$3,779.17$6.0KWM
8$22,826$1,062.22$34,881$6,670.19$12.1KWM
9$25,731$1,306.80$49,793$12,469.89$24.1KWM
10$29,147$1,614.90$78,432$25,153.90$49.3KWM

GILD vs WM: Complete Analysis 2026

GILDHealthcare

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Full GILD Calculator →

WMStock

Waste Management, Inc., through its subsidiaries, provides waste management environmental services to residential, commercial, industrial, and municipal customers in North America. It offers collection services, including picking up and transporting waste and recyclable materials from where it was generated to a transfer station, material recovery facility (MRF), or disposal site; and owns, develops, and operates landfill gas-to-energy facilities in the United States, as well as owns and operates transfer stations. As of December 31, 2021, the company owned or operated 255 solid waste landfills; 5 secure hazardous waste landfills; 96 MRFs; and 340 transfer stations. It also provides materials processing and commodities recycling services; recycling brokerage services, such as managing the marketing of recyclable materials for third parties; and other strategic business solutions. In addition, the company offers construction and remediation services; services related with the disposal of fly ash, and residue generated from the combustion of coal and other fuel stocks; in-plant services comprising full-service waste management solutions and consulting services; and specialized disposal services for oil and gas exploration and production operations. The company was formerly known as USA Waste Services, Inc. and changed its name to Waste Management, Inc. in 1998. Waste Management, Inc. was incorporated in 1987 and is headquartered in Houston, Texas.

Full WM Calculator →
📬

Get this GILD vs WM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GILD vs SCHDGILD vs JEPIGILD vs OGILD vs KOGILD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.